All companies
Baxter International logo
HealthcareBAX

Baxter International (BAX) Financial Forecast Calculator

Interactive 5-year forecast and DCF for Baxter International. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from Baxter International’s most recent SEC filings.

Revenue FY30
$9.23B
from $10.36B
FCF FY30
$869.0M
Margin 9.4%
Enterprise value
$15.56B
1.5× LTM revenue
Equity value
$6.14B
Net debt $9.42B
Revenue & free cash flow - history and 5-year forecast
Line (area)
Bars
Historicals from SEC EDGAR (grey). Forecast years (color) update live as you move the sliders.

Assumptions

Revenue growth (annual)
-2.3%
-10.0%baseline -2.3%40.0%
Gross margin
39.1%
5.0%baseline 39.1%90.0%
Capex % of revenue
5.2%
0.0%baseline 5.2%30.0%
WACC (discount rate)
9.00%
4.0%baseline 9.0%18.0%
Terminal growth
2.50%
0.0%baseline 2.5%5.0%

Need this as an Excel model?

Keep iterating on the Baxter International forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.

income_statement.xlsx
Income statement, brown brand palette
income_statement.xlsx
Income statement, green brand palette
income_statement.xlsx
Income statement, red brand palette

Frequently asked

What is Baxter International's core business focus after recent divestitures?+

Following recent divestitures, Baxter International is a global medical technology company focused on critical care, surgical products, and patient monitoring. Its portfolio includes Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals segments.

What are the primary revenue segments for Baxter International?+

Baxter International's continuing revenue is primarily driven by its Medical Products & Therapies segment (approximately 45%), Healthcare Systems & Technologies (approximately 40%), and Pharmaceuticals (approximately 15%). The company also generates significant international sales, comprising roughly 45% of total revenue.

What is the assumed revenue growth rate in the Baxter International financial model?+

The financial model for Baxter International incorporates a revenue growth assumption of approximately -2.28%. This figure is a critical input for projecting the company's future financial performance over the forecast horizon.

What is Baxter International's typical capital expenditure as a percentage of revenue?+

Baxter International typically allocates 4% to 5% of its revenue to capital expenditures. Approximately 60% of this is for maintenance, while 40% is for growth initiatives like upgrading IV manufacturing and expanding advanced surgery product capacity.

What is the main purpose of the Baxter International financial model?+

The Baxter International financial model serves as a sum-of-the-parts equity valuation and cash flow forecasting tool. It enables analysts to assess the company's standalone earnings power and its deleveraging trajectory after the Kidney Care business divestiture.

Can I access a downloadable financial model for Baxter International?+

Yes, an Excel financial model for Baxter International is available for download. This general corporate model provides a forecast horizon from FY2026 through FY2030.

Have more financial modelling questions? Contact us

Go further

Build the financial model you need with Fina

Browse templates, examples, and downloadable Excel models for the analysis you are trying to build. If you can't find your model, ask Fina to build a model for your specific needs.

Start for free
Excel financial model spreadsheet preview showing Customer Rollforward
Fina interactive chat interface preview